 Connection
Joshua Yarrow to Bone Morphogenetic Proteins
This is a "connection" page, showing publications Joshua Yarrow has written about Bone Morphogenetic Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.042 |
|
|
|
-
Phillips EG, Beggs LA, Ye F, Conover CF, Beck DT, Otzel DM, Ghosh P, Bassit ACF, Borst SE, Yarrow JF. Effects of pharmacologic sclerostin inhibition or testosterone administration on soleus muscle atrophy in rodents after spinal cord injury. PLoS One. 2018; 13(3):e0194440.
Score: 0.575
-
Beggs LA, Ye F, Ghosh P, Beck DT, Conover CF, Balaez A, Miller JR, Phillips EG, Zheng N, Williams AA, Aguirre JI, Wronski TJ, Bose PK, Borst SE, Yarrow JF. Sclerostin inhibition prevents spinal cord injury-induced cancellous bone loss. J Bone Miner Res. 2015 Apr; 30(4):681-9.
Score: 0.467
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|